Pharmaceutical Industry Information Portal

HomeDiscovery and Development

Discovery and Development

BMS, Merck enter into $2.3 billion partnership with Amphista to discover and develop small molecule protein degraders

Amphista Therapeutics, a global leader in the discovery and development of next generation targeted protein degradation (TPD) therapeutics, May 4th announced a strategic collaboration...

SK bioscience has reached the final stage of development of Korea’s first COVID-19 vaccine

SK bioscienceSK bioscience and GSK announced submission of a biologics license application for SKYCovione™ a recombinant protein-based COVID-19 vaccine candidate adjuvanted with GSK’s pandemic...

Eli Lilly’s obesity medication shows excellent results, up to 22.5% weight loss

Tirzepatide  achieved superior weight loss compared to placebo at 72 weeks of treatment in topline results from Eli Lilly and Company's SURMOUNT-1 clinical trial,...

Nkarta presented the first finished NK cell data showing multiple complete responses with full hematologic recovery

Nkarta, Inc., a biopharmaceutical company developing engineered natural killer cell therapies to treat cancer, announced positive preliminary Phase 1 data from independent dose finding...

New study shows, longer intervals between COVID-19 vaccinations result in 9 times more protective antibodies

New research has shown that a longer interval between primary COVID-19 vaccine doses can boost antibody production up to nine-fold. The study currently being presented at...

Roche awaits approval of EU’s first and only cancer immunotherapy for patients with early-stage NSCLC

Roche announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Tecentriq® (atezolizumab) as...
spot_img

Expert Articles

spot_img